Overview

Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
A Drug-Drug Interaction study to assess the effects of itraconazole, carbamazepine and quinidine on the Pharmacokinetics and Safety of EDP-235.
Phase:
Phase 1
Details
Lead Sponsor:
Enanta Pharmaceuticals, Inc
Treatments:
Carbamazepine
Itraconazole
Quinidine